English
This article is from Indian Journal of Endocrinology and Metabolism , volume 16 . Abstract Nutrient excess results in systemic inflammation in diabetes contributing to insulin resistance, dyslipidaemia and increased cardiovascular risk. GLP-1 agonists and DPP-4 inhibitors, which are now well accepted therapies for diabetes may play a unique role in modulating this inflammatory process. Incretin based therapies have shown beneficial anti-inflammatory effects on surrogate markers but cardiovascular outcome data is still lacking.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Inflammation and incretins. · Hatwal, Amitabh · Internet Archive